EMA Says No to Nouryant for Marketing Approval in Europe
A committee of the European Medicines Agency (EMA) is recommending the refusal of marketing authorization for Nouryant (istradefylline) — approved…
Articles by Margarida Maia, PhD
Turmeric Oil Derivatives May Help to Protect Dopaminergic Neurons
A compound naturally found in turmeric essential oil, called aromatic turmerone (ar-turmerone), and its derivatives were seen to protect dopaminergic…
Dancing May Improve Motor and Non-motor Symptoms
Training to dance to music on a weekly basis may slow the progression of both motor and non-motor symptoms of…
Therapeutic Solutions Files Patent for StemVacs Immunotherapy to Treat Parkinson’s
Therapeutic Solutions International has filed a patent for the use of a type of immune cell, called a dendritic…
Smoking History May Not Be Linked to Parkinson’s
Smoking history may not influence the severity of symptoms in Parkinson’s disease, a small study suggests. Moreover, in some individuals,…
Servier, Oncodesign Select LRRK2 Inhibitor for Preclinical Studies
Servier and Oncodesign have selected a LRRK2 inhibitor as their partnership program’s lead candidate for Parkinson’s disease and…
Caraway, AbbVie Ink Deal to Develop TMEM175-targeting Therapies
Caraway Therapeutics is partnering with AbbVie to develop and market Caraway’s small molecule therapies targeting TMEM175, a potassium…
Patient Willingness to Skip Flu Shots May Be Issue for COVID Vaccines
A considerable number of people with Parkinson’s disease living at home missed every flu vaccination given over five years…
CEPT Cocktail Protects Stem Cells in Lab, Opening Research Possibilities
A four-ingredient, small-molecule cocktail was seen to protect stem cells from the stresses of lab work better than existing agents,…
Study in Small, Hospitalized Patient Group Sees No Added COVID-19 Risks
Parkinson’s disease does not appear to make a person more susceptible to infection with the COVID-19-causing virus, or at…